BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30144432)

  • 21. Centrilobular fibrosis in long-term follow-up of pediatric liver transplant recipients.
    Martin SR; Russo P; Dubois J; Alvarez F
    Transplantation; 2002 Sep; 74(6):828-36. PubMed ID: 12364864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and risk factors of subclinical rejection after pediatric liver transplantation, and impact on allograft fibrosis.
    Zhang Z; Zhao S; Si Z; Wang Z; Dong C; Sun C; Zheng W; Kai W; Zhang W; Song Z; Gao W; Shen Z
    Clin Transplant; 2023 Feb; 37(2):e14894. PubMed ID: 36581321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time monitoring of acute liver-allograft rejection using the Banff schema.
    Demetris AJ; Ruppert K; Dvorchik I; Jain A; Minervini M; Nalesnik MA; Randhawa P; Wu T; Zeevi A; Abu-Elmagd K; Eghtesad B; Fontes P; Cacciarelli T; Marsh W; Geller D; Fung JJ
    Transplantation; 2002 Nov; 74(9):1290-6. PubMed ID: 12451268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation.
    Rocque B; Zaldana A; Weaver C; Huang J; Barbetta A; Shakhin V; Goldbeck C; Yanni G; Zielsdorf S; Kwon Y; Etesami K; Genyk Y; Zhou S; Kohli R; Emamaullee J
    Liver Transpl; 2022 May; 28(5):843-854. PubMed ID: 34954868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft histology characteristics in long-term survivors of pediatric liver transplantation.
    Ekong UD; Melin-Aldana H; Seshadri R; Lokar J; Harris D; Whitington PF; Alonso EM
    Liver Transpl; 2008 Nov; 14(11):1582-7. PubMed ID: 18975292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation.
    Grabhorn E; Binder TM; Obrecht D; Brinkert F; Lehnhardt A; Herden U; Peine S; Nashan B; Ganschow R; Briem-Richter A
    Transplantation; 2015 Sep; 99(9):1876-81. PubMed ID: 25706279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. US-guided percutaneous liver biopsy in pediatric liver transplant recipients.
    Mandal S; Miraglia R; Maruzzelli L; Liotta R; Tuzzolino F; Spada M; Riva S; Luca A
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):756-61. PubMed ID: 24509302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors of silent allograft fibrosis 10 years post-pediatric liver transplantation.
    Rhu J; Ha SY; Lee S; Kim JM; Choi GS; Joh JW; Lee SK
    Sci Rep; 2020 Feb; 10(1):1833. PubMed ID: 32019996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
    Kosola S; Lampela H; Jalanko H; Mäkisalo H; Lohi J; Arola J; Pakarinen MP
    Liver Transpl; 2013 Feb; 19(2):145-54. PubMed ID: 23109058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Graft Fibrosis, Inflammation, and Donor-specific Antibodies at Protocol Liver Biopsies in Pediatric Liver Transplant Patients: A Single-center Experience.
    Pinon M; Pizzol A; Chiadò C; David E; Chiusa L; Dell'Olio D; Isolato G; Amoroso A; Deaglio S; Catalano S; Tandoi F; Romagnoli R; Calvo PL
    Transplantation; 2022 Jan; 106(1):85-95. PubMed ID: 33496554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell infiltrate intensity is associated with delayed response to treatment in late acute cellular rejection in pediatric liver transplant recipients.
    Peters AL; Rogers M; Begum G; Sun Q; Fei L; Leino D; Hildeman D; Woodle ES
    Pediatr Transplant; 2023 May; 27(3):e14475. PubMed ID: 36691289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation.
    Taner T; Heimbach JK; Rosen CB; Nyberg SL; Park WD; Stegall MD
    Kidney Int; 2016 Apr; 89(4):909-17. PubMed ID: 26924059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
    Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.
    Feng S; Bucuvalas JC; Mazariegos GV; Magee JC; Sanchez-Fueyo A; Spain KM; Lesniak A; Kanaparthi S; Perito E; Venkat VL; Burrell BE; Alonso EM; Bridges ND; Doo E; Gupta NA; Himes RW; Ikle D; Jackson AM; Lobritto SJ; Jose Lozano J; Martinez M; Ng VL; Rand EB; Sherker AH; Sundaram SS; Turmelle YP; Wood-Trageser M; Demetris AJ
    Hepatology; 2021 May; 73(5):1985-2004. PubMed ID: 32786149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations.
    Hytiroglou P; Lee R; Sharma K; Theise ND; Schwartz M; Miller C; Thung SN
    Transplantation; 1993 Dec; 56(6):1389-94. PubMed ID: 7506452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.